The complement system

被引:631
作者
Sarma, J. Vidya [1 ]
Ward, Peter A. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
关键词
Complement; Activation pathways; Anaphylatoxins; BINDING-LECTIN; IMMUNE-RESPONSE; INNATE IMMUNITY; FRAGMENTS C5A; RECEPTOR; ACTIVATION; C5L2; DEFICIENCY; EXPRESSION; EVASION;
D O I
10.1007/s00441-010-1034-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The complement system consists of a tightly regulated network of proteins that play an important role in host defense and inflammation. Complement activation results in opsonization of pathogens and their removal by phagocytes, as well as cell lysis. Inappropriate complement activation and complement deficiencies are the underlying cause of the pathophysiology of many diseases such as systemic lupus erythematosus and asthma. This review represents an overview of the complement system in an effort to understand the beneficial as well as harmful roles it plays during inflammatory responses.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 61 条
[11]   Functions of the complement components C3 and C5 during sepsis [J].
Flierl, Michael A. ;
Rittirsch, Daniel ;
Nadeau, Brian A. ;
Day, Danielle E. ;
Zetoune, Firas S. ;
Sarma, J. Vidya ;
Huber-Lang, Markus S. ;
Ward, Peter A. .
FASEB JOURNAL, 2008, 22 (10) :3483-3490
[12]   Role of C5a-C5aR interaction in sepsis [J].
Guo, RF ;
Riedemann, NC ;
Ward, PA .
SHOCK, 2004, 21 (01) :1-7
[13]   Decay-accelerating factor modulates induction of T cell immunity [J].
Heeger, PS ;
Lalli, PN ;
Lin, F ;
Valujskikh, A ;
Liu, JB ;
Muqim, N ;
Xu, YY ;
Medof, ME .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (10) :1523-1530
[14]   Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation [J].
Holers, V. Michael ;
Kulik, Liudmila .
MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) :64-72
[15]   Defining the CD59-C9 binding interaction [J].
Huang, Yuxiang ;
Qiao, Fei ;
Abagyan, Ruben ;
Hazard, Starr ;
Tomlinson, Stephen .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (37) :27398-27404
[16]   Generation of C5a by phagocytic cells [J].
Huber-Lang, M ;
Younkin, EM ;
Sarma, JV ;
Riedemann, N ;
McGuire, SR ;
Lu, KT ;
Kunkel, R ;
Younger, JG ;
Zetoune, FS ;
Ward, PA .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) :1849-1859
[17]   Generation of C5a in the absence of C3: a new complement activation pathway [J].
Huber-Lang, Markus ;
Sarma, J. Vidya ;
Zetoune, Firas S. ;
Rittirsch, Daniel ;
Neff, Thomas A. ;
McGuire, Stephanie R. ;
Lambris, John D. ;
Warner, Roscoe L. ;
Flierl, Michael A. ;
Hoesel, Laszlo M. ;
Gebhard, Florian ;
Younger, John G. ;
Drouin, Scott M. ;
Wetsel, Rick A. ;
Ward, Peter A. .
NATURE MEDICINE, 2006, 12 (06) :682-687
[18]   A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2 [J].
Inal, JM ;
Sim, RB .
FEBS LETTERS, 2000, 470 (02) :131-134
[19]   Complement in multiple sclerosis: its role in disease and potential as a biomarker [J].
Ingram, G. ;
Hakobyan, S. ;
Robertson, N. P. ;
Morgan, B. P. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 155 (02) :128-139
[20]   C5L2 is a functional receptor for acylation-stimulating protein [J].
Kalant, D ;
MacLaren, R ;
Cui, W ;
Samanta, R ;
Monk, PN ;
Laporte, SA ;
Cianflone, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) :23936-23944